Skip to content

All Blog Posts

More articles

Driving Momentum: TransCelerate’s 2021 Year in Review

Despite closing out a second year of the COVID-19 pandemic, the R&D ecosystem continued to carry its momentum to modernize clinical trials and make them even more patient-friendly, accessible, and safe. Our 20 Member Companies worked diligently together to create solutions that can transform information flow in clinical development, how sponsors and sites interact with patients, and better manage regulations and data.

Our 2021 Annual Achievements Report is the most robust report to date, detailing the impact of our activity and documents the extensive list of new solutions that were developed across the 35 initiatives within TransCelerate and BioCelerate, our nonclinical subsidiary.

TransCelerate BioPharma publishes 2021 Annual Achievement Report

Some highlights include:

Additionally, the report illustrates the collaborative work that TransCelerate has engaged in, with Health Authorities like the FDA, EMA, and PMDA, or other organizations like CDISC, HL7, ACRO, and SCRS, to name a few.

Read the full 16-page report here. Previous annual reports can be found in our News Center.